Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Microenvironmental heterogeneity among triple negative breast cancer subtypes and the promise of precision medicine.

Braunstein LZ, Riaz N.

J Natl Cancer Inst. 2019 Oct 29. pii: djz209. doi: 10.1093/jnci/djz209. [Epub ahead of print] No abstract available.

PMID:
31665363
2.

Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.

Bekelman JE, Lu H, Pugh S, Baker K, Berg CD, de Gonzalez AB, Braunstein LZ, Bosch W, Chauhan C, Ellenberg S, Fang LC, Freedman GM, Hahn EA, Haffty BG, Khan AJ, Jimenez RB, Kesslering C, Ky B, Lee C, Lu HM, Mishra MV, Mullins CD, Mutter RW, Nagda S, Pankuch M, Powell SN, Prior FW, Schupak K, Taghian AG, Wilkinson JB, MacDonald SM, Cahlon O; RadComp (Radiotherapy Comparative Effectiveness Consortium).

BMJ Open. 2019 Oct 15;9(10):e025556. doi: 10.1136/bmjopen-2018-025556.

3.

Radiotherapy in the setting of hypersensitivity syndromes.

Billena C, Khan AJ, Cahlon O, Braunstein LZ.

Breast J. 2019 Sep 12. doi: 10.1111/tbj.13621. [Epub ahead of print] No abstract available.

PMID:
31513307
4.

Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes.

Xu AJ, DeSelm CJ, Ho AY, Gillespie EF, Braunstein LZ, Khan AJ, McCormick B, Powell SN, Cahlon O.

Adv Radiat Oncol. 2019 Mar 1;4(3):447-452. doi: 10.1016/j.adro.2019.02.004. eCollection 2019 Jul-Sep.

5.

Daily Fractionation of External Beam Accelerated Partial Breast Irradiation to 40 Gy Is Well Tolerated and Locally Effective.

Braunstein LZ, Thor M, Flynn J, Cost Z, Wilgucki M, Rosenbaum S, Zhang Z, Gillespie E, McCormick B, Khan A, Ho A, Cahlon O, Deasy JO, Powell SN.

Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):859-866. doi: 10.1016/j.ijrobp.2019.02.050. Epub 2019 Mar 7.

PMID:
30851350
6.

Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy.

Yu AF, Ho AY, Braunstein LZ, Thor ME, Lee Chuy K, Eaton A, Mara E, Cahlon O, Dang CT, Oeffinger KC, Steingart RM, Liu JE.

J Am Soc Echocardiogr. 2019 Apr;32(4):521-528. doi: 10.1016/j.echo.2018.12.009. Epub 2019 Feb 28.

PMID:
30826225
7.

Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.

Ho AY, Ballangrud A, Li G, Gupta GP, McCormick B, Gewanter R, Gelblum D, Zinovoy M, Mueller B, Mychalczak B, Dutta P, Borofsky K, Parhar P, Reyngold M, Braunstein LZ, Chawla M, Krause K, Freeman N, Siu CT, Cost Z, Arnold BB, Zhang Z, Powell SN.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1100-1108. doi: 10.1016/j.ijrobp.2018.11.045. Epub 2018 Nov 30.

PMID:
30508620
8.

Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy.

Abouegylah M, Braunstein LZ, Alm El-Din MA, Niemierko A, Salama L, Elebrashi M, Edgington SK, Remillard K, Napolitano B, Naoum GE, Sayegh HE, Gillespie T, Farouk M, Ismail AA, Taghian AG.

Breast Cancer Res Treat. 2019 Feb;174(1):179-185. doi: 10.1007/s10549-018-5053-y. Epub 2018 Nov 26.

PMID:
30478787
9.

ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.

Laird J, Braunstein LZ.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):648-649. doi: 10.1245/s10434-018-6889-4. Epub 2018 Oct 10. No abstract available.

PMID:
30306376
10.

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.

Gopal RK, Kübler K, Calvo SE, Polak P, Livitz D, Rosebrock D, Sadow PM, Campbell B, Donovan SE, Amin S, Gigliotti BJ, Grabarek Z, Hess JM, Stewart C, Braunstein LZ, Arndt PF, Mordecai S, Shih AR, Chaves F, Zhan T, Lubitz CC, Kim J, Iafrate AJ, Wirth L, Parangi S, Leshchiner I, Daniels GH, Mootha VK, Dias-Santagata D, Getz G, McFadden DG.

Cancer Cell. 2018 Aug 13;34(2):242-255.e5. doi: 10.1016/j.ccell.2018.06.013.

11.

Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.

Lowry KP, Braunstein LZ, Economopoulos KP, Salama L, Lehman CD, Gazelle GS, Halpern EF, Giess CS, Taghian AG, Lee JM.

Breast Cancer Res Treat. 2018 Aug;171(1):209-215. doi: 10.1007/s10549-018-4808-9. Epub 2018 May 10.

PMID:
29748762
12.

Potential Morbidity Reduction With Proton Radiation Therapy for Breast Cancer.

Braunstein LZ, Cahlon O.

Semin Radiat Oncol. 2018 Apr;28(2):138-149. doi: 10.1016/j.semradonc.2017.11.009. Review.

PMID:
29735190
13.

Reply to "Questions About In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy".

Laird J, Braunstein LZ.

Ann Surg Oncol. 2018 Nov;25(12):3779. doi: 10.1245/s10434-017-6286-4. Epub 2017 Dec 21. No abstract available.

PMID:
29270878
14.

Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Laird J, Lok B, Siu C, Cahlon O, Khan AJ, McCormick B, Powell SN, Cody H, Wen HY, Ho A, Braunstein LZ.

Ann Surg Oncol. 2018 Jan;25(1):154-163. doi: 10.1245/s10434-017-6209-4. Epub 2017 Nov 1.

15.

Analysis of somatic microsatellite indels identifies driver events in human tumors.

Maruvka YE, Mouw KW, Karlic R, Parasuraman P, Kamburov A, Polak P, Haradhvala NJ, Hess JM, Rheinbay E, Brody Y, Koren A, Braunstein LZ, D'Andrea A, Lawrence MS, Bass A, Bernards A, Michor F, Getz G.

Nat Biotechnol. 2017 Oct;35(10):951-959. doi: 10.1038/nbt.3966. Epub 2017 Sep 11.

PMID:
28892075
16.

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.

Polak P, Kim J, Braunstein LZ, Karlic R, Haradhavala NJ, Tiao G, Rosebrock D, Livitz D, Kübler K, Mouw KW, Kamburov A, Maruvka YE, Leshchiner I, Lander ES, Golub TR, Zick A, Orthwein A, Lawrence MS, Batra RN, Caldas C, Haber DA, Laird PW, Shen H, Ellisen LW, D'Andrea AD, Chanock SJ, Foulkes WD, Getz G.

Nat Genet. 2017 Oct;49(10):1476-1486. doi: 10.1038/ng.3934. Epub 2017 Aug 21.

PMID:
28825726
17.

The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy.

Mihalcik SA, Rawal B, Braunstein LZ, Capuco A, Wong JS, Punglia RS, Bellon JR, Harris JR.

Ann Surg Oncol. 2017 Jul;24(7):1868-1873. doi: 10.1245/s10434-016-5727-9. Epub 2017 Jan 30.

PMID:
28138856
18.

Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.

Mouw KW, Cleary JM, Reardon B, Pike J, Braunstein LZ, Kim J, Amin-Mansour A, Miao D, Damish A, Chin J, Ott PA, Fuchs CS, Martin NE, Getz G, Carter S, Mamon HJ, Hornick JL, Van Allen EM, D'Andrea AD.

Clin Cancer Res. 2017 Jun 15;23(12):3214-3222. doi: 10.1158/1078-0432.CCR-16-2017. Epub 2016 Nov 16.

19.

Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.

Braunstein LZ, Taghian AG, Niemierko A, Salama L, Capuco A, Bellon JR, Wong JS, Punglia RS, MacDonald SM, Harris JR.

Breast Cancer Res Treat. 2017 Jan;161(1):173-179. doi: 10.1007/s10549-016-4031-5. Epub 2016 Nov 3.

PMID:
27807809
20.

Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.

Kim J, Mouw KW, Polak P, Braunstein LZ, Kamburov A, Kwiatkowski DJ, Rosenberg JE, Van Allen EM, D'Andrea A, Getz G.

Nat Genet. 2016 Jun;48(6):600-606. doi: 10.1038/ng.3557. Epub 2016 Apr 25.

21.

Policy Implications of Proton Radiation Therapy: Toward an Evidence-Based Approach for Implementing Novel Oncologic Technologies.

Braunstein LZ, Warren LE.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):560-1. doi: 10.1016/j.ijrobp.2015.11.001. No abstract available.

PMID:
27084665
22.

Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.

Haradhvala NJ, Polak P, Stojanov P, Covington KR, Shinbrot E, Hess JM, Rheinbay E, Kim J, Maruvka YE, Braunstein LZ, Kamburov A, Hanawalt PC, Wheeler DA, Koren A, Lawrence MS, Getz G.

Cell. 2016 Jan 28;164(3):538-49. doi: 10.1016/j.cell.2015.12.050. Epub 2016 Jan 21.

23.

Molecular Phenotype, Multigene Assays, and the Locoregional Management of Breast Cancer.

Braunstein LZ, Taghian AG.

Semin Radiat Oncol. 2016 Jan;26(1):9-16. doi: 10.1016/j.semradonc.2015.08.002. Review.

PMID:
26617205
24.

Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management.

Braunstein LZ, Galland-Girodet S, Goldberg S, Warren LE, Sadek BT, Shenouda MN, Abi-Raad RF, MacDonald SM, Taghian AG.

Breast Cancer Res Treat. 2015 Dec;154(3):633-9. doi: 10.1007/s10549-015-3642-6. Epub 2015 Nov 20.

PMID:
26585579
25.

Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk.

Braunstein LZ, Chen MH, Dosoretz DE, Salenius SA, Katin MJ, Nanda A, D'Amico AV.

Clin Genitourin Cancer. 2015 Dec;13(6):555-61. doi: 10.1016/j.clgc.2015.04.010. Epub 2015 May 1.

PMID:
26003267
26.

Hypofractionated whole breast irradiation for early-stage breast cancer.

Braunstein LZ, Taghian AG.

JAMA. 2015 Apr 7;313(13):1370-1. doi: 10.1001/jama.2015.1641. No abstract available.

PMID:
25849184
27.

Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.

Braunstein LZ, Brock JE, Chen YH, Truong L, Russo AL, Arvold ND, Harris JR.

Breast Cancer Res Treat. 2015 Jan;149(2):555-64. doi: 10.1007/s10549-015-3273-y. Epub 2015 Jan 21.

PMID:
25604797
28.

Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.

Braunstein LZ, Niemierko A, Shenouda MN, Truong L, Sadek BT, Abi Raad R, Wong JS, Punglia RS, Taghian AG, Bellon JR.

Breast J. 2015 Mar-Apr;21(2):161-7. doi: 10.1111/tbj.12371. Epub 2015 Jan 6.

PMID:
25559656
29.

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.

Braunstein LZ, Chen MH, Loffredo M, Kantoff PW, D'Amico AV.

Prostate Cancer. 2014;2014:230812. doi: 10.1155/2014/230812. Epub 2014 Apr 22.

30.

Pathology quiz case 1. Diagnosis: multifocal granular cell tumor (GCT).

Braunstein LZ, Roberts DS, King EE, Lin HW, Goguen LA.

Arch Otolaryngol Head Neck Surg. 2012 Oct;138(10):977-9. doi: 10.1001/2013.jamaoto.44. No abstract available.

PMID:
23069833
31.

Pathology quiz case 2. Wegener granulomatosis (WG) of the orbit.

Braunstein LZ, Lin HW, Faquin WC, Fay A, Gray ST.

Arch Otolaryngol Head Neck Surg. 2011 Jul;137(7):724, 727-8. doi: 10.1001/archoto.2011.102-a. No abstract available.

PMID:
21768424

Supplemental Content

Loading ...
Support Center